The integration of Talley broadens Direct Healthcare Group’s comprehensive range of innovative, technologically advanced products for the care of patients with limited mobility. March 3, 2021 – Direct Healthcare Group (DHG), one of three key investments of ArchiMed’s MED Platform I – Europe’s largest healthcare fund – has purchased Talley Group. Talley provides cutting-edge vacuum…
American Preclinical Services’ offers state-of-the-art laboratory and analysis tools to NAMSA, the world’s only specialist in end-to-end medical device testing. March 2, 2021 – NAMSA – one of three key investments of ArchiMed’s MED Platform I – Europe’s largest healthcare fund – has purchased American Preclinical Services (APS). NAMSA and APS are leading contract research…
Leading global private equity healthcare specialist ArchiMed is expanding its New York City office with five appointments, adding to three transfers from the Lyon office. January 26, 2021 – The new hires at ArchiMed’s New York office are Partner Justin Bateman; Principal of Investor Relations Monica Holec; Associate Director Anthony Farias; and Strategic Partners Carlos…
The aggressive, ongoing acquisition program is consolidating a fragmented industry and turning BOMI into a full-service, one-stop shop for international healthcare logistics. January 25, 2021 – Through six acquisitions carried out between May, 2020 and January, 2021, healthcare logistics specialist BOMI Group is adding some 20 percent to its annual revenues. Going forward, annual revenues are…
The transactions – with more in the pipeline – put DHG on course to be the leading pan-European provider of products and solutions for the care of patients with limited mobility. January 25, 2021 – Direct Healthcare Group, a majority-owned portfolio company (and partner) of private equity healthcare specialist ArchiMed, increased its annual revenues in 2020…
With ArchiMed’s backing, the group is expected to rapidly become a European leader in diagnostics for cutting-edge, precision medical treatments for cancer. January 12, 2021 – Private equity healthcare specialist, ArchiMed, announces its acquisition of the Zyto group of companies, a fully integrated developer, manufacturer and distributor of technologically advanced cancer diagnostics tests and equipment…
To receive ArchiMed News, please complete the form below.